A technology-based pharmacist outreach was implemented in 2 (15.4%) studies [15,37], involving pharmacists engaging directly with other health care professionals to target specific high-risk prescribing errors, such as prescribing nonsteroidal anti-inflammatory drugs (NSAIDs) without proton pump inhibitors (PPIs) for patients with a history of peptic ulcers, beta-blockers for patients with asthma, and angiotensin-converting enzyme (ACE) inhibitors or diuretics without proper monitoring of renal function and electrolytes. This evidence concerns the gene ACE and asthma.